Hearing News Watch

CLAREMONT, CALIFORNIA — With tens of thousands of songs released every day, selecting tracks for playlists poses a significant challenge for streaming services and radio stations. Traditionally, these platforms have relied on human listeners and artificial intelligence, but their success rate in predicting hit songs has remained at a modest 50%. In a recent development, researchers in the United States

BOSTON, MASSACHUSSETTS — Lexie Hearing has been included in TIME’s prestigious TIME100 Most Influential Companies list for 2023. This renowned list recognizes companies that are making a significant impact worldwide. TIME gathered nominations from its extensive network of contributors, correspondents, and industry experts, and carefully evaluated each company based on criteria such as innovation, success, impact, and ambition. The resulting

EDEN PRAIRIE, MINNESOTA – Starkey has been named one of the 2023 Top 200 Workplaces in Minnesota by the Star Tribune.  This year’s Top Workplaces survey analysis included responses from more than 124,719 employees, and more than 5,000 Minnesota public, private and nonprofit organizations were invited to participate. The Top Workplace designation “is a testament to Starkey’s commitment to fostering an environment where employees can thrive both

MONTPELLIER, FRANCE — Sensorion, a clinical-stage biotechnology company specializing in hearing loss disorders, has announced promising preliminary results from its Phase 2a clinical trial of SENS-401 for residual hearing preservation following cochlear implantation. The trial evaluated the presence of SENS-401 in the cochlea after oral administration in adult participants with hearing impairment. The study confirmed the presence of SENS-401 in

HAMILTON, BERMUDA – Altamira Therapeutics Ltd. (Nasdaq: CYTO) announced this week that the U.S. Food and Drug Administration (FDA) has completed its safety review of the company’s Investigational New Drug (IND) application for AM-125, a betahistine nasal spray, in acute vestibular syndrome (AVS). The FDA has granted permission to initiate a Phase 2 clinical trial using AM-125 to treat posterior

A newly published case-control study conducted at Ghent University in Belgium has shed new light on the association of cognitive and motor deficits experienced by individuals with bilateral vestibulopathy (BV), a condition resulting from the reduction or absence of balance (vestibular) function of both ears. The study aimed to investigate the association between BV, hearing loss, and cognitive-motor performance, shedding

BOSTON, MASSACHUSSETTS — STAT Health has emerged from stealth mode to introduce a 24/7 in-ear wearable device designed to measure blood flow to the head. The wearable aims to provide a better understanding of symptoms such as dizziness, brain fog, headaches, fainting, and fatigue that occur when standing, which are commonly associated with illnesses like long COVID, postural orthostatic tachycardia

INDIANAPOLIS, INDIANA — U.S. Bankruptcy Judge Jeffrey Graham has dismissed the bankruptcy case of Aearo Technologies, a subsidiary of 3M, on Friday, rejecting an attempt to address nearly 260,000 lawsuits claiming that 3M military earplugs caused hearing loss in veterans and service members. Judge Graham ruled that Aearo, as a well-supported subsidiary, did not require bankruptcy protection due to its

ROCHESTER, NEW YORK — A recent serendipitous discovery in a neuroscience laboratory at the University of Rochester has revealed a potential association between Alzheimer’s disease plaques and hearing loss. Daxiang Na, a graduate student in Neuroscience, stumbled upon this unexpected finding while reviewing data for a project in the White Lab at the Del Monte Institute for Neuroscience. Na was

IOWA CITY, IA — The University of Iowa has announced the upcoming 30th annual Management of the Tinnitus & Hyperacusis Patient international conference, which is set to take place from August 10-11, both in-person and remotely. In-Person venue will be held at Wendell Johnson Speech & Hearing Center. The popular conference is intended for otologists, audiologists, psychologists, hearing aid specialists and